Pfizer Steps Up Asia-Specific Drug Discovery for Tuberculosis

doi:10.3833/pdr.v2010i4.1327

Pharma Deals Review, Vol 2010, No 4 (2010)

Pfizer Steps Up Asia-Specific Drug Discovery for Tuberculosis

PharmaDeals Analyst

Abstract

As part of its expansion in to emerging markets, Pfizer has started an Asia-specific diseases programme targeting multi drug resistant tuberculosis in partnership with Cumencor Pharmaceuticals and MicuRx Pharmaceuticals.

Add comment

This work is licensed under a Creative Commons Attribution 3.0 License.